4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-054710
EVP and General Counsel sold 10,000 shares at $95.00 ($950,000)
- EVP and General Counsel acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-08 | Exercise or conversion : show line 1 in the form | +10,000 | $54.50 | $545,000 | 34,293 | D |
| 2020-10-08 | Sale : show line 2 in the form | −10,000 | $95.00 | $950,000 | 24,293 | D |
| Open-market sales · 10,000 sh · avg $95.00 · $950,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-10-08 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −10,000 | $54.50 | 2026-06-20 | 10,000 | 35,000 | D |
Loading xslF345X03/doc4.xml…